GE HealthCare Technologies (GEHC) Change in Accured Expenses (2023 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Change in Accured Expenses came in at $19.0 million in Q2 2026, up 371.43% YoY from $4.0 million in Q2 2025, and up 107.6% on a QoQ basis from -$250.0 million in Q1 2026.
GE HealthCare Technologies (GEHC) Change in Accured Expenses (2023 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has 4 years of Change in Accured Expenses data on file, last reported at $19.0 million in Q2 2026.
- Quarterly Change in Accured Expenses rose 371.43% year-over-year to $19.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $70.0 million (down 28.57% YoY) and the FY2025 annual result came in at $94.0 million, up 141.03% from the prior year.
- Change in Accured Expenses improved to $19.0 million in Q2 2026, from -$250.0 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $178.0 million in Q3 2025 to a low of -$250.0 million in Q1 2026.
- A 4-year average of $14.1 million and a median of $67.5 million in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2025 — Change in Accured Expenses plunged 488.24% — and 2026, when it surged 371.43%.
- Tracing GEHC's Change in Accured Expenses over 4 years: stood at $116.0 million in 2023, then grew by 17.24% to $136.0 million in 2024, then fell by 9.56% to $123.0 million in 2025, then slumped by 84.55% to $19.0 million in 2026.
- The last three Change in Accured Expenses figures came in at $19.0 million (Q2 2026), -$250.0 million (Q1 2026), and $123.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | 92.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.00 Mn |
| Jun 30, 2026 | 19.00 Mn |
| Mar 31, 2026 | -250.00 Mn |
| Mar 31, 2026 | -250.00 Mn |
| Dec 31, 2025 | 123.00 Mn |
| Dec 31, 2025 | 123.00 Mn |
| Sep 30, 2025 | 178.00 Mn |
| Sep 30, 2025 | 178.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -200.00 Mn |
| Mar 31, 2025 | -200.00 Mn |
| Dec 31, 2024 | 136.00 Mn |
| Dec 31, 2024 | 136.00 Mn |
| Sep 30, 2024 | 169.00 Mn |
| Sep 30, 2024 | 169.00 Mn |
| Jun 30, 2024 | -232.00 Mn |
| Jun 30, 2024 | -232.00 Mn |
| Mar 31, 2024 | -34.00 Mn |
| Mar 31, 2024 | -34.00 Mn |